A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia

Wei Ying Jen; Elias Jabbour; Nicholas J. Short; Ghayas C. Issa; Fadi G. Haddad; Nitin Jain; Naveen Pemmaraju; Naval G. Daver; Lucia Masarova; Gautam Borthakur; Kelly Chien; Rebecca Garris; Hagop M. Kantarjian

doi:10.1002/ajh.27463

A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia

Wei Ying Jen, Elias Jabbour, Nicholas J. Short, Ghayas C. Issa, Fadi G. Haddad, Nitin Jain, Naveen Pemmaraju, Naval G. Daver, Lucia Masarova, Gautam Borthakur, Kelly Chien, Rebecca Garris, Hagop M. Kantarjian

Leukemia

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	2229-2232
Number of pages	4
Journal	American journal of hematology
Volume	99
Issue number	11
DOIs	https://doi.org/10.1002/ajh.27463
State	Published - Nov 2024

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.27463

Cite this

Jen, W. Y., Jabbour, E., Short, N. J., Issa, G. C., Haddad, F. G., Jain, N., Pemmaraju, N., Daver, N. G., Masarova, L., Borthakur, G., Chien, K., Garris, R., & Kantarjian, H. M. (2024). A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia. American journal of hematology, 99(11), 2229-2232. https://doi.org/10.1002/ajh.27463

Jen, WY , Jabbour, E , Short, NJ , Issa, GC , Haddad, FG , Jain, N , Pemmaraju, N , Daver, NG , Masarova, L , Borthakur, G , Chien, K, Garris, R & Kantarjian, HM 2024, 'A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia', American journal of hematology, vol. 99, no. 11, pp. 2229-2232. https://doi.org/10.1002/ajh.27463

@article{6eea6b4e0e9443dbb4ebca0df3a852f9,

title = "A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia",

author = "Jen, {Wei Ying} and Elias Jabbour and Short, {Nicholas J.} and Issa, {Ghayas C.} and Haddad, {Fadi G.} and Nitin Jain and Naveen Pemmaraju and Daver, {Naval G.} and Lucia Masarova and Gautam Borthakur and Kelly Chien and Rebecca Garris and Kantarjian, {Hagop M.}",

year = "2024",

month = nov,

doi = "10.1002/ajh.27463",

language = "English (US)",

volume = "99",

pages = "2229--2232",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "John Wiley and Sons Inc.",

number = "11",

}

TY - JOUR

T1 - A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia

AU - Jen, Wei Ying

AU - Jabbour, Elias

AU - Short, Nicholas J.

AU - Issa, Ghayas C.

AU - Haddad, Fadi G.

AU - Jain, Nitin

AU - Pemmaraju, Naveen

AU - Daver, Naval G.

AU - Masarova, Lucia

AU - Borthakur, Gautam

AU - Chien, Kelly

AU - Garris, Rebecca

AU - Kantarjian, Hagop M.

PY - 2024/11

Y1 - 2024/11

UR - http://www.scopus.com/inward/record.url?scp=85202512459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85202512459&partnerID=8YFLogxK

U2 - 10.1002/ajh.27463

DO - 10.1002/ajh.27463

M3 - Letter

C2 - 39194286

AN - SCOPUS:85202512459

SN - 0361-8609

VL - 99

SP - 2229

EP - 2232

JO - American journal of hematology

JF - American journal of hematology

IS - 11

ER -

A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this